Antigenic variants of Mycoplasma gallisepticum major surface lipoprotein, pMGA, are encoded by a large gene family. In this study sequence analyses of the PCR-amplified pMGA genes showed two types of sequences similar to the pMGA1.2 gene in M. gallisepticum strains. They differed in the sequence encoding a proline-rich region (PRR) at the N-terminus of the pMGA protein. The type A genes had sequences similar to the published pMGA1.2 gene sequence of strain S6, whereas the type B genes lacked the second repetitive segment encoding PTPN sequence within PRR and were similar to the published sequence of PG31 strain. Low in vitro passages of M. gallisepticum strains isolated recently in Slovenia from four avian species showed very different expression patterns of pMGA1.2 and pMGA1.9 genes. Among isogenic populations of S6 B and IHB1 strains a high frequency of pMGA antigenic variants lacking an epitope for monoclonal antibody (mAb) 71 was found. Strain IHB1 clones, which synthesized pMGA recognized by mAb 71, transcribed pMGA genes whose partial sequence encoded the amino acid sequence 262 TNGDEPRSVS of the mAb 71 epitope. Other IHB1 clones synthesized pMGA variants with different isoelectric points, lacking the epitope for mAb 71, but expressing downstream epitopes for other mAbs. Our study suggests that a molecular basis for pMGA antigenic variation lies in the corresponding changes at the DNA level. ß
Introduction
Mycoplasma gallisepticum is a major respiratory pathogen of chickens and turkeys causing great economic losses to the poultry industry. Natural infection with M. gallisepticum can occur also in many other avian species, including songbirds [1] . Like other mollicutes, M. gallisepticum also lacks a cell wall and has only a plasma membrane [2] , which contains about 200 proteins, many of which are lipoproteins. The S6 strain has as much as 35 lipoproteins and many of them are immunodominant antigens recognized by chicken antibodies [3] . The most abundant membrane proteins in M. gallisepticum are pMGA, lipoproteins of about 67 kDa and isoelectric point (pI) 5.5, encoded by the pMGA gene family [3^5] . In di¡erent M. gallisepticum strains the number of pMGA genes varies from 32 to 70 [6, 7] . Nine members of the pMGA gene family in S6 strain have been sequenced (pMGA1.1p MGA1.9) and a high degree of sequence identity ( s 95%) has been found between pMGA1.1 and pMGA1.2 genes, whereas all the other pMGA genes exhibit much lower overall identity [6^10] . In M. gallisepticum, the pMGA gene sequences have been reported only for strains S6 and PG31 [11] . In addition, the N-terminal amino acid sequencing of the pMGA has been done for the F and R strains and con¢rmed a synthesis of proteins similar to the pMGA1.2 [8, 9] . Data for other M. gallisepticum strains are not available.
The objective of the present study was to determine the 5P-end of the pMGA genes in our recent M. gallisepticum ¢eld isolates and to investigate patterns of pMGA protein synthesis in M. gallisepticum populations at low in vitro passages. We expected that the sequence data showing the di¡erences at the 5P-end of the pMGA gene might be useful for strain di¡erentiation. Patterns of pMGA expression and occurrence of antigenically distinct pMGA1.9 protein have been previously investigated only in a highly passaged S6 strain [8, 15] . However, we already ¢fth passage [12] . For this reason we used ¢ve additional M. gallisepti-cum strains and studied patterns of pMGA and pMGA1.9 expression at low passages. Additionally, we examined whether the distinct expressed pMGA variants of isogenic lineages of S6 B and IHB1 strains are accompanied by the corresponding change at the DNA level.
Materials and methods

M. gallisepticum strains
The origin of M. gallisepticum strains (S6 208 , S6 JMB , S6 B , A5969 HK , PG31, 6/85, G11, IHB1, ULB921 and ULB931) and their classi¢cation on the basis of reactivity with 12 monoclonal antibodies (mAbs) was described elsewhere [12, 13] . Other reference strains used were S6 PFM [4] , TS100, a temperature sensitive mutant of the S6 strain [20] and A5969 LG , a low passage culture from a chicken trachea. Our recent M. gallisepticum isolates PPT 2 from a chicken trachea, ULB971 from a pheasant trachea and ULB992 from the infraorbital sinus of a peacock were also examined. In addition, K4421/AS strain culture, a reisolate from the air sacs in turkeys previously infected with K4421/A strain (a recent isolate from the turkey respiratory tract in the USA) was used. M. gallisepticum cultures were grown in mycoplasma broth or agar media containing 12% horse serum [12] .
PCR and DNA sequence analysis
Genomic DNA was isolated as described [13] . The polymerase chain reaction (PCR) was performed using primers based on the pMGA1.2 sequence from M. gallisepticum S6 strain (GenBank Accession no. L28424). Primers PMGA1.F (5P-AGTTATTGACTTAACTTTAAGTG-3P) and PMGA1.R (5P-TCATCGGACTTACTTTTTCTGC-TGG-3P) are located at the 5P-end (nt 1288^2571) of the pMGA1.2 gene and generated a 1.3 kb-long PCR product. Primers PMGA2.F (5P-CCTCAAAAAGAAAACGCAA-CA-3P) and PMGA2.R (5P-TTTAGCACCAGTACCAG-CTAAAC-3P) ampli¢ed a 317-bp DNA segment (nt 1977^2294) containing the region which encodes the epitope for mAb 71. PCR was carried out on the PTC-100 thermal cycler (MJ Research, Watertown, MA, USA) using the temperature pro¢le of initial denaturation at 95³C for 5 min, followed by 34 cycles at 95³C for 1 min, 54³C for 1 min and 72³C for 1.5 min and a ¢nal extension step at 72³C for 2 min. PCR products were puri¢ed with QIAEX II agarose gel extraction kit (Qiagen, Valencia, CA, USA) and sequenced using the ABI Prism1 BigDye Primer Cycle Sequencing kit and ABI Prism 310 automated £uorescent sequencer (Applied Biosystems, Perkin Elmer, Foster City, CA, USA). The sequence data were analyzed using BLAST algorithm at the NCBI server (http://www.ncbi.nlm.nih.gov). The enumeration of nucleotide positions of DNA sequences is based on the reference sequence of the pMGA1.2 gene (GenBank Accession no. L28424).
The total RNA was extracted from the Mycoplasma cells grown to the late exponential phase [15] using Trizol 0 reagent (GibcoBRL, Paisley, UK) and used as a template in a reverse transcription (RT) reaction. The ¢rst strand cDNA synthesis was initiated using the PMGA1.R primer and MuLV reverse transcriptase (Perkin Elmer, Foster City, CA, USA), followed by the RT-PCR using either PMGA1.F and PMGA1.R or PMGA2.F and PMGA2.R primers.
Antibodies
The mAb 66 that reacts with pMGA1.1 and mAbs 71 and 86 that react also with pMGA1.2 were described elsewhere [4, 8, 15] . The mAb A3 reacts with pMGA1.1 and pMGA1.2 [14, 16] . Three mAbs 6A10, 9D4 and 12D10, recognizing pMGA1.1 and pMGA1.2 have already been described in our previous studies [12, 14, 17] . The mAb K1, which inhibited hemagglutination of M. gallisepticum [18] , reacted poorly with puri¢ed pMGA1.1 [14] . However, immunoa¤nity-puri¢ed 67-kDa protein, obtained from the PG31 strain using mAb K1, reacted with mAbs 71, 86 and A3, indicating that mAb K1 recognizes a pMGA1.2 protein (data not shown). Antibodies against the synthetic peptide C 1 TTPTPSPAPNPNPPSNG+C, which was coupled to keyhole limpet hemocyanin and represented the N-terminal part of pMGA1.1 [4, 17] , were raised in a rabbit and designated pAb D1. The rabbit was immunized intramuscularly with 1 mg synthetic peptide in Freund's complete adjuvant and boosted ¢ve times with 1 mg peptide in Freund's incomplete adjuvant in 1^3-week intervals. Blood was collected 7 days after the last immunization. Rabbit polyclonal antibodies pAb t pMGA against truncated recombinant pMGA1.1 (aa residues from 37 to about 300) and rabbit antiserum to pMGA1.9 were also used. Antibodies to pMGA1.9 protein do not react with pMGA1.1 or pMGA1.2 but only with pMGA1.9, which is a 82-kDa polypeptide synthesized in S6 strain [8, 15] .
Mapping of mAb epitopes on the pMGA
Immunoblotting with the PhastSystem (Pharmacia-LKB, Uppsala, Sweden) was used to determine regions of the pMGA molecule recognized by mAbs [12] . The whole length puri¢ed pMGA1.1 protein, its fragments, cleaved either with protease V-8 (Glu-C) or trypsin, or a truncated recombinant pMGA (residues from 37 to about 300) were used for the analysis [4, 5] . Mapping of the epitopes for mAbs was conducted with the SPOTS system (Genosys, Cambridge, UK). Epitopes in the N-terminal region (residues from 1 to 10 and from 11 to 20) and in the C-terminal region of pMGA (residues from 520 to 625) were represented by synthetic peptides (decamers), corresponding to the pMGA amino acid sequence. The central region of the pMGA was screened with 19 peptides corresponding to the regions with the highest antigenic index.
Analysis of the pMGA antigenic variants
Indirect immunoperoxidase assay (IIPA) was used for the analysis of pMGA antigenic variants expressed on the colonies of clonal populations of the M. gallisepticum strains [12] . Consecutive IIPA enabled precise analysis of the pMGA antigenic variants characterized by di¡erent antibodies. In the ¢rst immunostaining, colonies stained dark brown using an appropriate mAb and secondary antibodies that were labeled with horseradish peroxidase (HRP) and diaminobenzidine tetrahydrochloride (DAB). In the second immunostaining, the previously unstained colonies stained blue using another mAb or pAb D1, HRP-conjugate and True-Blue (Kirkegaard and Perry Laboratories, MA, USA). M. gallisepticum populations selected by the IIPA were examined also by immunoblotting, including consecutive immunoblots using di¡erent antibodies and di¡erent chromogens [12, 19] .
To determine pIs of pMGA antigenic variants, isoelectric focusing (IEF) in PhastGel IEF 3-9 gels was used. The separated proteins were transferred onto an Immobilon1-P membrane (Millipore, Bedford, MA, USA) by di¡usion for 20 min at 35³C. For the analysis of pMGA antigenic variants with di¡erent pI pMGA-speci¢c antibodies were used (see Fig. 5 ).
Results and discussion
3.1. Two types of pMGA1.1/1.2 genes exist in M. gallisepticum strains
All pMGA genes with determined sequences (pMGA1.1p MGA1.9) have highly conserved leader peptide sequence and encode proline-rich regions (PRR) at the N-terminus with the cysteine (C 1 ) at the ¢rst position [6, 8, 10] . Our study was focused on the pMGA1.1 and pMGA1.2 genes because of the importance of their products as adhesins and immunodominant antigens [3, 4, 12] . The presence of the large pMGA gene family in M. gallisepticum required a selection of pMGA1.1/pMGA1.2 speci¢c PCR primers (PMGA1.F/PMGA1.R), which directed the synthesis of the 1.3-kb PCR fragment (PMGA1FR). Sequencing of this fragment revealed pMGA1.1 and/or pMGA1.2 gene speci¢c sequences. In all ¢eld isolates of M. gallisepticum, the 5P-end contained a pMGA1.2 speci¢c sequence which switched in the downstream region into the pMGA1.1 speci¢c sequence. All strains had an identical deduced leader peptide sequence and C 1 TTPTPN sequence at the N-terminal end of the mature pMGA protein.
Regarding the length di¡erences in the sequence encoding PRR two types of pMGA1.1/1.2 genes were observed Fig. 1 . Alignment of the N-terminal amino acid sequences deduced from the pMGA gene sequences of di¡erent M. gallisepticum strains. Sequences are aligned to maximize homology between the corresponding segment of the pMGA1.2 [6, 9] . Strains are separated in two groups: in the group with pMGA sequence type A, which has PTPN repeated motif and in the group with type B sequence, which lacks PTPN motif. Dashes indicate missing amino acids in the type B sequence. The pMGA gene sequence of the type strain PG31 [11] , representing the type B sequence, is also shown. ( Fig. 1) . Type A encodes a longer PRR similar to the pMGA1.2 gene in the S6 strain [5, 6] . Type B encodes a shorter PRR similar to the published sequence of the pMGA gene expressed in the type strain PG31 [11] . Genes of the type B lack a motif that encodes sequence PTPN (Fig. 1) . Di¡erences in the length of PRR are interesting because such regions are characteristic also for the Nterminal part of Mycoplasma synoviae hemagglutinin which has over 63% sequence identity with pMGA1.7 protein [10] and for cytadhesins of Mycoplasma pneumoniae and Mycoplasma genitalium [2] . It is possible, therefore, that di¡erent lengths of PRR might play a role in the adherence of mycoplasmas. On the other hand, the identi¢ed di¡erences in the length of PRR could be explored to di¡erentiate between types A and B on the basis of a simple PCR-based length polymorphism assay. Among the strains with known N-terminal pMGA sequences, S6 PFM and F [6, 9] have the type A, whereas strains R [9] and PG31 [11] have the type B pMGA sequences.
As shown in Fig. 2 , a polymorphic site within the sequence downstream of the string of seven adenine residues ( 1575 AAAAAAACA) was found. In the same region, changes of the pMGA gene sequences occurred even in isogenic lineages. The epitope with the sequence VDYKKTQNTL, partially encoded by the sequence shown in Fig. 2 , is immunodominant for chickens infected with M. gallisepticum (data not shown). Changes in the sequence can occur also in other regions of the pMGA gene which encode immunodominant epitopes (see Section 3.3). It is possible that such changes are involved in the immune evasion strategy of M. gallisepticum in its natural hosts.
Expression of pMGA genes in M. gallisepticum at low in vitro passages
Analyses of pMGA genes and their expression have already been done with M. gallisepticum strains S6 and PG31 that were isolated about 40 years ago and are highly adapted to in vitro growth conditions [6, 11] . The expression patterns of pMGA genes can change during the adaptation of M. gallisepticum to the in vitro environment. For this reason, we have examined six strains isolated from di¡erent avian species in Slovenia and USA during the last few years.
Field isolate ULB931 did not express pMGA genes up to the ¢fth passage [12] . In higher passages of this strain, the PMGA1FR sequence type B was obtained. The deduced amino acid sequence showed 98,7% identity (over the ¢rst 154 residues) with the pMGA gene expressed in the type strain PG31 [11] . The synthesized 67-kDa pMGA protein was recognized by all mAbs to pMGA, including mAb 66 to pMGA1.1. However, from its clone C1, four subclones, which did not synthesize 67-kDa pMGA protein, were obtained. Further analysis showed that these subclones synthesized a W80-kDa protein, recognized by pMGA1.9-speci¢c antibodies [8, 15] .
Second passage of the strain ULB992 from a peacock did not express pMGA recognized by mAbs 66, 71, 86, 6A10 and K1. This strain had a type A sequence with 97.2% amino acid identity with the pMGA1.2 over the ¢rst 178 residues. In contrast to mAbs against pMGA that did not stain colonies, over 99% of colonies reacted in the IIPA with pMGA1.9-speci¢c antibodies. The switch in the expression of pMGA genes (pMGA1.1CpMGA1.9) can be induced in S6 PFM strain by mAb 66 against pMGA1.1 [8] and is associated with the (GAA) 12 repeated motif upstream of the promoter region of the expressed gene [15] . In the exudate from the sinus of a peacock we detected high levels of antibodies against the 67-kDa pMGA (data not shown). Therefore, it seems likely that the local antibodies caused a drift towards the pMGA1.9 expressing population in the ULB992 culture.
In the ULB921 strain, sequence analysis did not show any di¡erence between the sequences of the pMGA genes of in vivo populations (exudate of the infraorbital sinus) and its in vitro culture at the eighth passage. Both cultures revealed pMGA gene of type A. However, up to the fourth passage, ULB921 strain did not synthesize detectable amounts of pMGA proteins. Not surprisingly, the G11 strain which is epizootiologically related to strain ULB921 revealed identical PMGA1FR sequence and started to synthesize pMGA protein after the fourth in vitro passage. It seems that strains ULB921 and G11 can not switch the expression from the pMGA1.2 to pMGA1.9 because the pMGA1.9 synthesis was never detected in their cultures. The predicted amino acid sequence of G11 and ULB921 PMGA1FR product had over 95% identity with the published sequence of pMGA1.2.
ULB971 strain isolated from the trachea of a pheasant caused about 20% mortality in the £ock of pheasants infected with this strain. Strain ULB971 had PMGA1FR sequence of type B, clearly di¡erent from the homologous sequences in other M. gallisepticum strains isolated in Slovenia during the last decade (Fig. 1) . Interestingly, the great majority of the ULB971 fourth passage population (99% of colonies) expressed pMGA protein recognized by mAbs 71 and 86, whereas mAbs 6A10, 12D10 and 9D4 did not detect pMGA in the same population. The PMGA1FR ampli¢cate of strain ULB971 had the sequence encoding the pMGA1.1 epitope for mAb 71 ( 262 TNGDEPRVS) but it apparently encoded a pMGA antigenic variant lacking several epitopes in the downstream region (see Fig. 4 and Section 3.3). K4421/AS culture was isolated from the air sac of a turkey 10 days after the experimental infection with the strain K4421/A, which was isolated in the USA. This strain had a PMGA1FR sequence of type B, similar to strains 6/85 and S6 B . IIPA analysis revealed that the majority of colonies of the K4421/AS population synthesized pMGA detected by mAbs A3, K1, 6A10, 9D4 and 12D10, whereas only a minority of them reacted with mAb 71. The above data indicate a very diverse expression pattern of pMGA genes in low passages of di¡erent M. gallisepticum strains. Moreover, strains ULB971 and K4421/AS synthesized pMGA antigenic variants lacking epitopes for mAb 71 or other mAbs (K1, 6A10 and 12D10), which inhibit M. gallisepticum hemagglutination [4, 12, 18] . We suggest that such pMGA variants contribute to the wide antigenic diversity of M. gallisepticum strains which has been observed in hemagglutination-inhibition tests [21] .
pMGA antigenic variants in isogenic populations
The pMGA gene family is the largest known family of translatable genes in mollicutes and has an extraordinary potential for diversifying antigenic structure on the surface of M. gallisepticum cells [2, 6, 7, 15] . The switch in the expression from one to another pMGA gene is well documented [8, 15] , whereas pMGA antigenic variants caused by the change in the sequence of distinct expressed pMGA genes have not been reported yet. We have observed that M. gallisepticum strain S6 B and its derivative IHB1 often synthesized pMGA lacking the epitope for mAb 71. Using the SPOTS system we have found that mAb 71 reacts with the peptide TNSDEPRSIS, corresponding to the residues 266^275 of the pMGA1.2 [5, 6] . However, mAb 71 reacted also with the immunoa¤nity-puri¢ed pMGA1.1 protein [4, 5] . Capability of S6 B to generate di¡erent pMGA antigenic variants is unique, because such variants were never observed in other S6 strain cultures like S6 PFM , S6 208 and S6 JMB (data not shown).
From the S6 B culture C4 clone was selected because in the IIPA less than 5% of its colonies reacted with mAb 71 and about 95% of colonies reacted with other antibodies against pMGA. From the C4 culture a subclone C4/1 was isolated. A great majority of its colonies reacted with mAbs 71, 86 and pAb D1 but only a few of them reacted with other mAbs against pMGA. Immunoblot analysis con¢rmed the presence of di¡erent pMGA antigenic variants in C4 and C4/1 cultures (Fig. 3A,B) . Determination of epitopes for pAb D1, mAbs 71 and A3 on the pMGA molecule and the approximate positioning of epitopes for mAbs 86, 6A10 and 12D10, enabled better insight into the pMGA regions which presumably changed antigenic determinants (Fig. 4) .
To examine the molecular basis for the loss of epitopes, pMGA genes from clones C4 and C4/1 were sequenced. In both clones PMGA1FR sequences were type B, similar to the sequence of IHB1 strain (Fig. 1) . The downstream sequences varied considerably and the predicted amino acid sequence of clone C4 19 DTNPGGGQG changed in its subclone C4/1 into the sequence 19 DTNPGDEQG. The PMGA1FR sequences of these two clones di¡ered also in other regions, where in addition to the pMGA1.2 or pMGA1.1-speci¢c sequences also unique sequences were found (Fig. 2) .
Clones 6/2 and 8/3 of the IHB1 strain, which is derivative of the S6 B strain [12] , also synthesized pMGA variants lacking epitope for mAb 71. The pMGA gene sequences of those clones were similar to those of either the C4 or C4/1 clone from the S6 B strain. From the IHB1 culture that lacks mAb 71 epitope, 40 clones were established. In only one clone (C6), the majority of the population expressed pMGA with an epitope for mAb 71. From this clone, a subclone C6/20 in which the great majority ( s 95% of colonies) synthesized pMGA with epitopes for mAbs 71 and 86, and a subclone C6/29 in which a minority of the population ( 6 5% colonies) synthesized pMGA reacting with mAb 71, were selected for further analysis. Surprisingly, the C6/29 culture had a 32 times higher hemagglutination titer for chicken erythrocytes than the C6/20 culture. This culture had one of the highest hemagglutination titers ever recorded in our laboratory but the association of pMGA with such a high titer is not understood yet.
The predicted amino acid sequence based on the PMGA1FR product was identical for clones C6/20 and C6/29 up to the region, which was diverse also in the S6 B clones. In this region amino acid sequences were 19 DTNPGDEQ and 19 DTNPGAGQ for clones C6/20 and C6/29, respectively. In addition, some other regions were also di¡erent, including a region representing the putative epitope for mAb 71. Consistent with the presence of the epitope for mAb 71, this region encoded the sequence 262 TNGDEPRSVS in the C6/20 clone. In the C6/ 29 clone, however, the corresponding sequence was 262 QTGDEPQKGF, which might explain the loss of the epitope for mAb 71. Using the RT-PCR with primers PMGA2.F/PMGA2.R we have con¢rmed that clone C6/ 20 as well as its two consecutive subclones that expressed epitopes for mAb 71, all expressed the sequence 262 TNGDEPRSVS. In the clone C6/29 and its subclones the RT-PCR with primers PMGA2.F and PMGA2.R failed to amplify the region, which encodes the epitope recognized with mAb 71. This might be due to the sequence polymorphism of the annealing site for PMGA2.F/PMGA2.R primers what might be associated with the synthesis of the variant of pMGA protein with di¡erent epitopes and pI.
Based on the observation that clones 6/20 and 6/29 produced pMGA with epitope for mAb 86, but lacked epitopes for either mAb 71 or for mAbs 6A10, 9D4, 12D10 and A3, we assumed that the two pMGA antigenic variants di¡er in the primary amino acid sequence. This assumption is also supported with distinct pIs in both variants. Indeed, as shown in Fig. 5A ,B immunoblotting demonstrated that pMGA forms with epitopes for mAbs 71 and 86 had a pI of about 5.5, whereas pMGA antigenic variants which lost the epitope for mAb 71 (but gained epitopes for four other mAbs) had a more acidic pI (about 5.0). The pMGA variant, lacking the epitope for mAb 71 retained epitopes for pAb t pMGA, which recognizes truncated pMGA1.1 protein (residues 37^300). Interestingly, one clone from the 6/20 subpopulation, which lost the epitope for mAb 86, synthesized pMGA which revealed a shift of pI from 5.5 to 5.8. Thus, there was an apparent indication that changes of the pMGA antigenic determinants are associated with the changes in the primary structure of the corresponding pMGA forms.
We suggest that changes in the DNA sequence of expressed pMGA genes can cause synthesis of pMGA antigenic variants observed in S6 B and IHB1 strains. In contrast to the other S6 strains (S6 PFM , S6 208 and S6 JMB ), S6 B and IHB1 strains can not switch the pMGA synthesis from the 67-kDa pMGA to pMGA1.9. The synthesis of the pMGA1.9 protein was also never detected in their cultures. Therefore we assume that an increased capability of the S6 B cultures to synthesize 67-kDa pMGA variants may be a compensation for its incapability to express pMGA antigenic variants by switching the expression from pMGA to pMGA1.9. In addition to the S6 B and IHB1 clones, we observed pMGA antigenic variants lacking the epitope for mAb 71 also in several other M. gallisepticum strains (G11, ULB 921, PPT 2 , Pet2) and also in vaccinal strain 6/85 which is widely used for the vaccination of poultry £ocks. Thus, we emphasize again [12] that the M. gallisepticum antigens and vaccines must be prepared from cultures with well de¢ned antigenic determi-nants, especially because of the fact that along with the pMGA also several other immunodominant proteins undergo variable expression.
